drugset / Trial / NCT06240390

Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain

NCT06240390

RandomizedParallel-groupTriple-blindTreatment

Summary

the goal of this clinical trial is to compare in cancer patients: Is ultrasound-guided percutaneous neuromodulation useful for Anterior Knee Pain relief in cancer patients? Participants will receive treatments of ultrasound-guided percutaneous neuromodulation and pharmacological treatment Researchers will compare ultrasound-guided percutaneous neuromodulation versus pharmacological treatment to see if Anterior Knee Pain is reduced

Timeline

Start
2024-05-01
Primary completion
2024-08-30
Completion
2025-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified
Subject Hydrocodone Unknown
Subject Hydromorphone Other / unclassified
Subject Methadone Other / unclassified
Subject Morphine Other / unclassified
Subject Oxycodone Other / unclassified
Subject Oxymorphone Small molecule
Subject Tapentadol Small molecule
Subject Tramadol Other / unclassified

Indications